2-25161179-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP3BP4_StrongBS1BS2

The NM_000939.4(POMC):ā€‹c.706C>Gā€‹(p.Arg236Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00434 in 1,613,852 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R236Q) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.0028 ( 1 hom., cov: 33)
Exomes š‘“: 0.0045 ( 28 hom. )

Consequence

POMC
NM_000939.4 missense

Scores

6
9
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:3B:3O:1

Conservation

PhyloP100: 6.21
Variant links:
Genes affected
POMC (HGNC:9201): (proopiomelanocortin) This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 6: AlphaMissense, BayesDel_noAF, Cadd, Eigen, PROVEAN, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.017676592).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00284 (433/152332) while in subpopulation AMR AF= 0.00542 (83/15304). AF 95% confidence interval is 0.00448. There are 1 homozygotes in gnomad4. There are 219 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 28 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POMCNM_000939.4 linkuse as main transcriptc.706C>G p.Arg236Gly missense_variant 3/3 ENST00000395826.7 NP_000930.1
POMCNM_001035256.3 linkuse as main transcriptc.706C>G p.Arg236Gly missense_variant 4/4 NP_001030333.1
POMCNM_001319204.2 linkuse as main transcriptc.706C>G p.Arg236Gly missense_variant 4/4 NP_001306133.1
POMCNM_001319205.2 linkuse as main transcriptc.706C>G p.Arg236Gly missense_variant 3/3 NP_001306134.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POMCENST00000395826.7 linkuse as main transcriptc.706C>G p.Arg236Gly missense_variant 3/32 NM_000939.4 ENSP00000379170 P1

Frequencies

GnomAD3 genomes
AF:
0.00284
AC:
433
AN:
152214
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000965
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.00543
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00384
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00269
AC:
675
AN:
250890
Hom.:
3
AF XY:
0.00259
AC XY:
352
AN XY:
135696
show subpopulations
Gnomad AFR exome
AF:
0.000802
Gnomad AMR exome
AF:
0.00336
Gnomad ASJ exome
AF:
0.00775
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.000187
Gnomad NFE exome
AF:
0.00396
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00449
AC:
6569
AN:
1461520
Hom.:
28
Cov.:
32
AF XY:
0.00436
AC XY:
3173
AN XY:
727076
show subpopulations
Gnomad4 AFR exome
AF:
0.000627
Gnomad4 AMR exome
AF:
0.00322
Gnomad4 ASJ exome
AF:
0.00704
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.000188
Gnomad4 NFE exome
AF:
0.00531
Gnomad4 OTH exome
AF:
0.00495
GnomAD4 genome
AF:
0.00284
AC:
433
AN:
152332
Hom.:
1
Cov.:
33
AF XY:
0.00294
AC XY:
219
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.000962
Gnomad4 AMR
AF:
0.00542
Gnomad4 ASJ
AF:
0.00865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00384
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00398
Hom.:
0
Bravo
AF:
0.00357
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.00229
AC:
278
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00534
EpiControl
AF:
0.00445

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:3Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:3Uncertain:1Benign:1
Pathogenic, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Pathogenic, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Pathogenic, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 23, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 16, 2019The R236G variant in the POMC gene has been reported previously in the heterozygous state in multiple individuals with obesity (Miraglia del Giudice et al., 2001; Challis et al., 2002; Buono et al., 2005; Lee et al., 2006; Creemers et al., 2008; Dubern et al., 2008; Shabana et al., 2016; Nordang et al., 2017). While it has also been reported in control populations, the frequency appears to be higher in individuals with obesity, and R236G is felt to confer an increased risk for obesity (Shabana et al., 2016). The R236G variant is observed in 234/66,206 (0.35%) alleles from individuals of European (non-Finnish) background in the ExAC dataset (Lek et al., 2016). The R236G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution disrupts the dibasic cleavage site at a position that is conserved across species (Challis et al., 2002). Functional studies demonstrate that R236G is associated with expression of an abnormal fusion protein that interferes with MC4R signaling (Challis et al., 2002). We interpret R236G as a risk allele. -
Obesity due to pro-opiomelanocortin deficiency Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterDec 21, 2022_x000D_ Criteria applied: PS3_SUP, PS4_SUP, PP1, PP3 -
Obesity due to pro-opiomelanocortin deficiency;C4054476:Inherited obesity Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJan 26, 2023- -
POMC-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 31, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Obesity, early-onset, susceptibility to Other:1
risk factor, no assertion criteria providedliterature onlyOMIMAug 15, 2002- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.84
BayesDel_addAF
Uncertain
0.097
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D;D;D;D;T
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.82
T;.;.;.;T
MetaRNN
Benign
0.018
T;T;T;T;T
MetaSVM
Uncertain
0.60
D
MutationAssessor
Uncertain
2.6
M;M;M;M;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-6.4
D;D;D;D;D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.0010
D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;.
Polyphen
1.0
D;D;D;D;.
Vest4
0.98
MVP
0.96
MPC
1.1
ClinPred
0.048
T
GERP RS
4.2
Varity_R
0.82
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28932472; hg19: chr2-25384048; COSMIC: COSV99063086; COSMIC: COSV99063086; API